Eradicating therapy of Helicobacter pylori with lansoprazole and amoxicillin in duodenal ulcer patients;Tratamiento erradicador de Helicobacter pylori con lansoprazol y amoxicilina en pacientes ulcerosos duodenales

Revista Clinica Espanola

Volumn 196, Issue 9, 1996, Pages 588-593

  Gisbert, J P ^a,b   Boixeda, D ^a   Alvarez Baleriola I ^a   Martin De Argila C ^a   Bermejo, F ^a   Aller, R ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b NONE   (Spain)

Author keywords

amoxicillin; duodenal ulcer; Helicobacter pylori; lansoprazole

Indexed keywords

AMOXICILLIN; LANSOPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; ORAL DRUG ADMINISTRATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROSPECTIVE STUDIES;

EID: 0029795775     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Marshall BJ, Warren JR Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1984, 1 1 311-1.314.
2. McNulty CAM. Watson DM Spiral bacteria of the gastric antrum Lancet 1984. 1.1 068-1.073
3. Humphreys H, Bourke S, Dooley C, et al. Effect of treatment on Campylobacter pylori in peptic disease a randomised prospective trial. Gut 1988, 29:279-283.
4. Dooley CP, Cohen H The clinical significance of Campylobacter pylori. Ann Intern Med 1988; 108:70-79.
5. Marshall BJ Helicobacter pylori. Am J Gastroenterol 1994; 89.S116-127.
6. a ed St. Louis, Mosby, 1994; 109-116.
7. NIH Consensus Conference Helicobacter pylori in peptic ulcer disease JAMA 1994; 272:65-69
8. Chiba N, Rao BV, Rademaker JW. Hunt RH Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylon. Am J Gastroenterol 1992; 87:1 716-1.722
9. Borody TJ, Cole P, Noonan S, et al Long term Campylobacter pylori recurrence post eradication Gastroenterology 1988; 94:A43
10. Borody TJ, Brandl S, Andrews P, Ferch N, Jankiexicz E, Hyland L. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol 1994, 89:33.
11. Bell GD, Powell KU, Burridge SM, et al. Experience with «triple» an-n-H. pylori eradication therapy: side effects and importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6:427-431.
12. Labenz J, Gyenes E, Rühl GH, et al. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized and controlled study. Gut 1993; 34.1.167-1.170.
13. Spencer CM, Faulds D. Lansoprazole A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs 1994; 48:404-430.
14. Mégraud F, Bouchard S, Larnouliatte H, et al. Proton pump inhibitors have an antimicrobial activity against Helicobacter pylon. Gastroenterology 1991: 100 (suppl):A123.
15. Sherman P, Shames B, Loo V, et al. Omeprazole therapy for Helicobacter pylon infection. Scand J Gastroenterol 1992, 27:1.018-1 022.
16. Mazzio L, Cellini L, Grossi L, et al. Treatment of Helicobacter pylori infection with an association of omeprazole and roxytromicine: a study in vivo and in vitro. Ital J Gastroenterol 1991; 23 (suppl 2):111.
17. Bode G, Malfertheiner P. The influence of omeprazole on growth, morphology and viability of Helicobacter pylori in vitro. Ital J Gastroenterol 1991; 23 (suppl 2):35-38.
18. Loo VG, Sherman P, Matlow AG, et al Helicobacter pylori infection in a pediatric population, in vitro susceptibilities to omeprazole and eight antimicrobial agents. Antimicrob Agents Chemother 1992; 36:1.133-1.135.
19. Suerbaum S, Leying H, Klemm K, et al. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylon. Eur J Microbiol Infect Dis 1991; 10:92-93.
20. Williams V, Janisch HD, Langmaack H, et al. Omeprazole and ursodeoxycholic-acid (UDCA) have selective activity against Helicobacter pylori. Gastroenterology 1992; 102.A189.
21. Unge P, Gad A, Gnarpe H, et al Does omeprazole improve antimicrobial therapy directed towards Campylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol 1989; 24 (suppl 167):49-54.
22. Cariani G, Vandelli A, Santini D, et al. Omeprazole in short-term treatment of Helicobacter pylori positive duodenal ulcer. Ital J Gastroenterol 1991; 23:597-598
23. Rokkas T, Karameris A, Archavlis E, et al. Omeprazole effectiveness on Helicobacter pylori in duodenal ulcer patients. Gastroenterology 1991, 100 (suppl):A148.
24. Weil J, Bell GD, Powell K, et al. Omeprazole and Helicobacter pylori. temporary suppression rather than true eradication. Aliment Pharmacol Ther 1991; 5:309-313.
25. Louw JA, Zak J, Jaskiewicz K, et al. Omeprazole may dear but does not eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4:481-485.
26. Bayerdörffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4:697-702
27. Kuipers EJ, Klinkenberg-Knol EC, Festen HPM, et al. Long-term omeprazole therapy does not affect Helicobacter pylon status in most patients. Scand J Gastroenterol 1993; 28:978-980.
28. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole protom pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 35:490-4-96.
29. Mégraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori. Lancet 1991; 337:1.486
30. Verdu EF, Fraser R, Armstrong D, Blum AL. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori positive volunteers. Scand J Gastroenterol 1994, 29.1.065-1.069.
31. Barradell LB, Faulds D, McTavish D, Lansoprazole A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders Drugs 1992, 44:225-250.
32. Marshall BJ. Campylobacter pylori: its link to gastritis and peptic ulcer disease. Rev Infect Dis 1990; 12 (suppl 1):S87-S93
33. Tamura K, Yamamoto A, Shinovama N, Tanaka M. Clinical effect of AG-1749 on gastric ulcer: histological change of gastric mucosa and effect on Helicobacter pylon. Yakuri to Chiryo 1990; 18:4.877-4.890.
34. Pallone F, Luzza F, Delle Fave G, et al. Lansoprazole and Helicobacter pylon infection. Clinical Therapeutics 1993; 15 (suppl B):49-57.
35. Louw JA, Lucke W. Jasklewicz K Helicobacter pylon suppression by the proton pump inhibitors (PPI's): a class effect? S Afr Med J 1993; 83:784.
36. Jhala NC, McFarland M, Brightman S, Morale B, Jennings D. Effect of short term treatment with lansoprazole on Helicobacter pylori and antral gastritis in patients with duodenal ulcer. Gastroenterology 1992; 102:A91.
37. Lanza F, Goff J, Scowcroft C, Jennings D, Greski-Rose P, and the lansoprazole study group. Double-blind comparison of lansoprazole, ranitidine, and placebo m the treatment of acute duodenal ulcer Am J Gastroenterol 1994; 89-1.191-1 200.
38. Lamouliatte H, Bernard PH, Cayla R. Effect of lansoprazole against Helicobacter pylori in vivo Ir J Med Sci 1992; 161:A96.
39. De Korwin JD, Joubert M, Bazin N, et al. Lansoprazole versus lansoprazole plus antibiotics in the treatment of Helicobacter pylori gastric infection Gastroenterology 1993, 104:A67.
40. Wilde MI, McTavish D. Omeprazole: an update of its pharmacology and therapeutic use in acid-related disorders Drugs 1994; 48:91-132.
41. Burette A, Glupczynski Y, Deprez C, Crombez A. Lansoprazole plus roxytromycin and metronidazole for eradication of Helicobacter pylori: results of a single blind pilot study Gastroenterology 1993; 104:A49.
42. Pérez-García JI, Carpintero P, Jiménez I, et al. Does Helicobacter pylon eradication differ in peptic ulcer from chronic gastritis? World Congress of Gastroenterology. Los Angeles, 1994;106P.
43. Labenz J, Leverkus F, Börsch G. et al. Omeprazole plus amoxicillin for cure of Helicobacter pylon infection Factors influencing the treatment success. Scand J Gastroenterol 1994, 29.1.070-1.075.
44. Govosdis B, Triantafillidis JK, Tsami-Pandi A, Cheracakis P, Barbatzas C. Comparison of the effect of the administration of omeprazole plus amoxicilline us lansoprazole plus amoxicilline on the Helicobacter pylon eradication from dental plaque and saliva of patients with active duodenal ulcer. World Congress of Gastroenteroly. Los Angeles, 1994; 66P.
45. Hatlebakk JG, Nesje LB, Hausken T, Berstad A. Lansoprazole and amoxicillin oral suspension in the treatment of peptic ulcer disease. 3rd United European Gastroenterology Week. Oslo. June 25-29. 1994;A1.455.
46. Lamouliatte H, Megraud F, De Mascarel A, et al. Does omeprazole improve amoxycillin therapy directed towards C pylon associated chronic gastritis? Proceedings of the Second Meeting of the European Campylobacter pylori Study Group. Klin Wochenschr 1989; 67.37.
47. De Koster E, Nyst JF, Deprez C, et al. Helicobacter pylon treatment: disappointing results with amoxicillin plus omeprazole It J Gastroenterol 1991; 23 (suppl 2):105.
48. Bell GD, Powell KU, Weil J, et al. Experience with omeprazole in combination with either amoxycillin or colloidal bismuth subcitrate in patients with metronidazole-resistant Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3:923-926.
49. Bell GD, Powell KU, Burridge SM, et al. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole resistant Helicobacter pylon. Aliment Pharmacol 1992, 6:751-758
50. Logan RPH, Rubio MA, Gummetr PA, et al Omeprazole and amoxycillin suspension for Helicobacter pylori. Ir J Med Sci 1992; 161 (suppl 10).16.
51. Bell GD, Powell KU, Burridge SM, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens Q J Med 1993; 86:743-750.
52. Lamouliatte H, Cayla R, Zerbib F, et al. Dual therapy versus triple therapy for Helicobacter pylori eradication. Preliminary results of a randomized controlled trial Gastroenterology 1993; 106:A120.
53. Labenz J, Stoke M, Dominan C, et al. Omeprazole plus amoxicillin or clarithromycin for eradication of Helicobacter pylon in duodenal ulcer disease. Am J Gastroenterol 1993; 88:1.511.
54. Cayla R, Werbib F, Mascarel A de, et al. Dual therapy with high dose of omeprazole versus triple therapy using omeprazole in combination with two antibiotics for Helicobacter pylori eradication: results of a randomized controlled trial among 100 patients. Am J Gastroenterol 1994; 89:1.366.
55. Logan RPH, Schaufelberger HD, Gummett PA, et al. Helicobacter pylori eradication with dobuble therapy. The 2nd International Conference on the Macrolides, Azalides and Streptogramins. Venecia, 1994; 55P.
56. Gisbert JP, Mur M, Sainz S, et al. ¿Es útil la asociacion de omeprazol y amoxicilina en el tratamiento enradicador de Helicobacter pylori en Espan̄a? Rev Esp Enferm Dig 1996; 88:99-106.
57. Gad A, Unger P. Antibacterial therapy of Helicobacter pylon associated peptic ulcer disease: a new strategy The Swedes go for it (editorial) J Clin Gastroenterol 1994; 19:6-10.
58. McNulty CAM. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. En. Rathbone BJ, Hearley RV, eds. Campylobacter pylon and gastroduodenal disease. Oxford: Blackwell Scientific Publications, 1989; 209-216
59. Armstrong D, Viani F, Siegrisi H, et al Does omeprazole increase gastric bacterial counts, nitrite or total nitrose compounds (NOC) in healthy subjects? Gastroenterology 1992; 102:A34.
60. Hunt RH. pH and Hp-gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism. Am J Gastroenterol 1993; 88:481-483.
61. Hunt RH. Hp and pH: implications for the eradication of Helicobacter pylori Scand J Gastroenterol 1993; 28 (suppl 196):12-16
62. Nagata K, Satoh H, Iwahi T, Simoyama T, Tamura T. Potent inhibitory action on the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H pylori cells. Antimicrob Agents Chemother 1993; 37:769-774
63. Unge P. Ekström P Effects of combination therapy with omeprazole and antibiotic on Helicobacter pylori and duodenal disease. Scand J Gastroenterol 1993, 28 (suppl 196):17-18
64. Rauws EA, Langenberg W, Houthoff HJ. Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94.33-40.
65. Valle J, Seppala K, Sipponen P. Disappearance of gastritis after eradication of Helicobacter pylori. a morphometric study. Scand J Gastroenterol 1991, 26:1 057-1 062
66. Patchett S, Beanie S, Leen E, Keane C, O'Morain C. Helicobacter pylori and duodenal ulcer recurrence Am J Gastroenterol 1992; 87:24-27.